{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:03:26Z","timestamp":1788545006979,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370930"],"award-info":[{"award-number":["31370930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["13431900600"],"award-info":[{"award-number":["13431900600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["15XD1524900"],"award-info":[{"award-number":["15XD1524900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pasteur Foundation","award":["SPHRF2013003"],"award-info":[{"award-number":["SPHRF2013003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.034","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T04:35:13Z","timestamp":1428726913000},"page":"2335-2341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2015.03.034_bib0135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","article-title":"Diseases caused by enterovirus 71 infection","volume":"28","author":"Lee","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.034_bib0140","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2015.03.034_bib0145","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"Mar (1)","key":"10.1016\/j.vaccine.2015.03.034_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.034_bib0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"Apr (20)","key":"10.1016\/j.vaccine.2015.03.034_bib0160","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the far East?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"issue":"Oct","key":"10.1016\/j.vaccine.2015.03.034_bib0165","article-title":"Review of enterovirus 71 vaccines","author":"Chong","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2015.03.034_bib0170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"Jun (3)","key":"10.1016\/j.vaccine.2015.03.034_bib0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.6.3.381","article-title":"Virus-like particles: flexible platforms for vaccine development","volume":"6","author":"Chackerian","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"Mar (15)","key":"10.1016\/j.vaccine.2015.03.034_bib0180","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.034_bib0185","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS ONE"},{"issue":"Feb (7)","key":"10.1016\/j.vaccine.2015.03.034_bib0190","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.vaccine.2011.12.081","article-title":"Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles","volume":"30","author":"Lin","year":"2012","journal-title":"Vaccine"},{"issue":"Jul (34)","key":"10.1016\/j.vaccine.2015.03.034_bib0195","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"issue":"Jul (32)","key":"10.1016\/j.vaccine.2015.03.034_bib0200","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2015.03.034_bib0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71","volume":"186","author":"Ku","year":"2012","journal-title":"J Virol Methods"},{"issue":"May","key":"10.1016\/j.vaccine.2015.03.034_bib0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2014.02.015","article-title":"A murine model of coxsackievirus A16 infection for anti-viral evaluation","volume":"105","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"issue":"Apr (1)","key":"10.1016\/j.vaccine.2015.03.034_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2015.03.034_bib0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2012.09.024","article-title":"Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies","volume":"187","author":"Liu","year":"2013","journal-title":"J Virol Methods"},{"issue":"Jun (9882)","key":"10.1016\/j.vaccine.2015.03.034_bib0225","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"Feb (9)","key":"10.1016\/j.vaccine.2015.03.034_bib0230","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"issue":"Feb (9)","key":"10.1016\/j.vaccine.2015.03.034_bib0235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2015.03.034_bib0240","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4161\/hv.21739","article-title":"Production of EV71 vaccine candidates","volume":"8","author":"Chong","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"Jun (12)","key":"10.1016\/j.vaccine.2015.03.034_bib0245","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","article-title":"Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production","volume":"98","author":"Ahmad","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"issue":"Jun (11)","key":"10.1016\/j.vaccine.2015.03.034_bib0250","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong","year":"2014","journal-title":"J Virol"},{"issue":"Oct (43)","key":"10.1016\/j.vaccine.2015.03.034_bib0255","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1016\/j.vaccine.2010.08.052","article-title":"Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield","volume":"28","author":"Chung","year":"2010","journal-title":"Vaccine"},{"issue":"Dec (1)","key":"10.1016\/j.vaccine.2015.03.034_bib0260","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T16:50:20Z","timestamp":1537721420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":26,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15003333"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}